Boston Scientific (BSX)

Cost of Revenue

$6.06B

TTM · Period ending: · USD

BSX logo

BSX Cost of Revenue

Latest reported$6.06B
BSX TTM Cost of Revenue ($0.00 → $6.06B)
High-resolution chart · PNG

BSX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
802,000,000
751,000,000
742,000,000
782,000,000
865,000,000
883,000,000
900,000,000
915,300,000
832,800,000
749,000,000
659,000,000
567,000,000
502,400,000
482,700,000
455,900,000
435,200,000
403,800,000
367,200,000
339,600,000
365,800,000
326,900,000
298,200,000
277,000,000
230,700,000
206,300,000
180,100,000
153,100,000
153,800,000
146,200,000
139,100,000
133,900,000
129,300,000
124,200,000
118,300,000
111,800,000
81,200,000
52,700,000
25,700,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.